U.S., July 10 -- ClinicalTrials.gov registry received information related to the study (NCT07057024) titled 'Contribution of Virtual Reality Eye Tracking in the Identification of Schizophrenia, Bipolar and Depression' on Dec. 30, 2024.
Brief Summary: Schizophrenia (SCZ), bipolar disorder (BP), and depression (DEP) are systematically associated with a severe impairment of the overall abilities of patients, which precludes them from functioning adequately in daily life. A large body of literature emphasises the importance of identifying specific markers for these pathologies to prevent or anticipate the emergence of new psychopathological symptoms.
As a result, one of the current research challenges is to develop new, faster, and more relia...